Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 25, 2018

Albiglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease

The Lancet

 

Additional Info

The Lancet
Albiglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Cardiovascular Disease (Harmony Outcomes): A Double-Blind, Randomised Placebo-Controlled Trial
Lancet 2018 Oct 01;[EPub Ahead of Print], AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, NP Jones, LA Leiter, AE Rosenberg, KN Sigmon, MC Somerville, KM Thorpe, JJV McMurray, S Del Prato

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading